Packaging & Logistic

In the pharmaceutical supply chain, secondary packaging is often overshadowed by the primary container that holds the medicine. However, the boxes, cartons, and shipping...

The pharmaceutical industry is currently witnessing one of its most significant shifts in history, moving from static, paper-based information to dynamic, interactive systems. This...

FABRX has started a fully automated approach to pharmacy compounding and has moved into real-world production, with the FABRX M3DIMAKER demonstrating large-scale pharmaceutical 3D...

Bluesight, a provider of hospital intelligence solutions, has formally entered into a strategic partnership with Pharma Logistics, a company specializing in pharmaceutical reverse distribution...

LogiPharma 2026 has concluded on a high, bringing together more than 2,300 life sciences supply chain professionals from around the world for three days...

Ensuring the long-term viability of genetic medicines requires a profound understanding of the complex interactions that govern nanoparticle integrity. By subjecting lipid-based delivery systems to rigorous environmental stress, researchers can identify the specific pathways of degradation and implement sophisticated stabilization strategies. This commitment to durability not only extends the shelf life of vital treatments but also simplifies the logistical challenges of global distribution, ensuring that life-saving RNA therapies remain potent and effective from the manufacturing floor to the patient's bedside.

Navigating the complexities of the single-use bioprocess systems supply chain requires a proactive approach to risk management and supplier collaboration. As the biopharmaceutical industry grows increasingly dependent on disposable technologies, establishing resilience through multi-sourcing, rigorous quality audits, and strategic inventory management is essential for maintaining manufacturing continuity and patient safety.